From NASH to MASH: New Terms for Liver Diseases Unveiled at the 2023 Cardiometabolic Health Congress
Cardiometabolic Health Congress
OCTOBER 26, 2023
A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. Robert H. Eckel, MD On Thursday, Oct. 19, 2023, attendees of the 18 th Annual CMHC in Boston heard from experts in hepatology and endocrinology in a session titled The Intersection of MASH and Cardiometabolic Risk: Applying Advanc
Let's personalize your content